Senate Finance Committee Drug Pricing Changes – Market Driven or More Destructive Price Controls?
The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce… Read More
Value Our Health: Stop Discriminatory Value Assessments
Millions of Americans are living with chronic illnesses and disabilities. In generations past, we did not live well or long with these conditions. Read More
Binding Arbitration Is Government Price Controls Hiding in Plain Sight
Prescription drug affordability might just be the last truly bipartisan issue in Washington. Read More
Pelosi’s Price Control Committees Will Destroy Research and Development into New Medicines
Opinion: Gov’t would create a panel to weigh some combo of politics, bureaucratic inertia and left-wing economic ignorance… Read More
Importing Drug Price Controls
This week, Senate Finance Committee Chairman Chuck Grassley made news when he publicly opposed a Trump Administration proposal to tie Medicare payments for drugs to the prices paid by other… Read More
FreedomWorks Foundation Hand Delivers Comments on HHS Price Controls Rule
In opposition to the proposed rule by the Department of Health and Human Services (HHS), over 5,600 FreedomWorks grassroots activists signed on to our formal comment that was hand-delivered today… Read More
The American Consumer Institute Releases Paper on the Effects of Adopting Foreign Price Controls on Drugs
Today, The American Consumer Institute Center for Citizen Research (ACI), a non-profit educational and research organization, released a white paper, “How International Reference Pricing for Prescription Drugs Would Hurt… Read More
MOORE: CONGRESS SHOULD THINK TWICE ABOUT IMPORTING DRUG PRICES
Almost all Americans want to see lower prices for prescription drugs. Americans don’t deserve to be gouged when they need life-saving drugs. It’s also unfair that Americans often pay higher… Read More
How socialist price controls will harm American patients
The Trump administration is planning to propose one of the biggest changes to Medicare in decades. The draft rule aims to reduce government spending by linking Medicare drug reimbursement rates… Read More
Evan Lubline: Policy change would harm state’s Medicare beneficiaries
In the United States, an estimated 43 million family members—including spouses, children and siblings—are serving as home caregivers for people 50 and older. Medicare is a key support for millions… Read More